688131.SH
Shanghai Haoyuan Chemexpress Co. Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 91.66
−5.88%Sep 11, 2026, 08:32 UTC
Shanghai Chenxiao, Shanghai Chenmai and Shanghai Chenxi, pre-IPO employee shareholding platforms of Haoyuan Pharma, plan to reduce their combined stake in the company by no more than 2.34% via centralized bidding between September 17 and December 16, 2026.
Source:Aug 26, 2026, 10:37 UTC
Haoyuan Pharmaceutical proposed a cash dividend of 0.90 yuan per 10 shares for the first half of 2026, totaling 19.1911 million yuan, representing 11.21% of net profit attributable to shareholders.
Source:Aug 16, 2026, 13:57 UTC
Haoyuan Pharmaceutical disclosed that as of the end of Q1 2026, its small-molecule order backlog was 860 million yuan, growing quarter-over-quarter for six consecutive quarters, and ADC order backlog exceeded 100 million yuan.